Murray Dallan (CIK 0002022303)

Latest company ownership

Role: Chief Customer Officer
Shares held
16,644
Last filed at
Mar 11, 2025
Confidence Score
50.3
2025Q4
Confidence Score History
2024Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 7, 2025 Mar 11, 2025 Sarepta Therapeutics, Inc. Chief Customer Officer Sell 97.5 +4,543 13.50% $373.8K
Mar 6, 2025 Mar 10, 2025 Sarepta Therapeutics, Inc. Chief Customer Officer Sell 40.0 -9,162 -24.55% $950.1K
Mar 4, 2025 Mar 6, 2025 Sarepta Therapeutics, Inc. Chief Customer Officer Sell 42.5 -1,685 -7.84% $170.8K
Mar 3, 2025 Mar 4, 2025 Sarepta Therapeutics, Inc. Chief Customer Officer Sell 42.5 -711 -3.20% $73.8K
Jun 21, 2024 Jun 25, 2024 Sarepta Therapeutics, Inc. Chief Customer Officer Sell 40.0 -2,352 -9.65% $387.2K
May 2, 2024 May 6, 2024 Sarepta Therapeutics, Inc. Chief Customer Officer Sell 17.5 -3,635 -16.70% $508.9K